ATE294799T1 - Hydrochloride kondensierter heterozyklen - Google Patents

Hydrochloride kondensierter heterozyklen

Info

Publication number
ATE294799T1
ATE294799T1 AT00931547T AT00931547T ATE294799T1 AT E294799 T1 ATE294799 T1 AT E294799T1 AT 00931547 T AT00931547 T AT 00931547T AT 00931547 T AT00931547 T AT 00931547T AT E294799 T1 ATE294799 T1 AT E294799T1
Authority
AT
Austria
Prior art keywords
hydrochlorides
condensed heterocycles
heterocycles
condensed
benzylüthiazolid
Prior art date
Application number
AT00931547T
Other languages
English (en)
Inventor
Takashi Fujita
Toshihiko Fujiwara
Takashi Izumi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15340495&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE294799(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of ATE294799T1 publication Critical patent/ATE294799T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT00931547T 1999-05-24 2000-05-24 Hydrochloride kondensierter heterozyklen ATE294799T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14351399 1999-05-24
PCT/JP2000/003325 WO2000071540A1 (en) 1999-05-24 2000-05-24 Hydrochloride of fused-heterocycle compound

Publications (1)

Publication Number Publication Date
ATE294799T1 true ATE294799T1 (de) 2005-05-15

Family

ID=15340495

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00931547T ATE294799T1 (de) 1999-05-24 2000-05-24 Hydrochloride kondensierter heterozyklen

Country Status (25)

Country Link
US (1) US6706746B2 (de)
EP (1) EP1180519B1 (de)
KR (2) KR100748053B1 (de)
CN (1) CN1156473C (de)
AT (1) ATE294799T1 (de)
AU (1) AU763731B2 (de)
BR (1) BR0010914A (de)
CA (1) CA2375017C (de)
CZ (1) CZ297927B6 (de)
DE (1) DE60019919T2 (de)
DK (1) DK1180519T3 (de)
ES (1) ES2240099T3 (de)
HK (1) HK1042087B (de)
HU (1) HU229340B1 (de)
IL (1) IL146568A0 (de)
MX (1) MXPA01012044A (de)
NO (1) NO321578B1 (de)
NZ (1) NZ515570A (de)
PL (1) PL209389B1 (de)
PT (1) PT1180519E (de)
RU (1) RU2214410C2 (de)
TR (1) TR200103353T2 (de)
TW (1) TWI284533B (de)
WO (1) WO2000071540A1 (de)
ZA (1) ZA200109576B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
EP1695716A2 (de) 2000-12-26 2006-08-30 Sankyo Company, Limited Medizinische Zusammensetzungen enthaltend ein Diuretikum und einen Insulin-Sensibilisator
US6756399B2 (en) * 2001-06-29 2004-06-29 The United States Of America As Represented By The Department Of Health And Human Services Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and intervention agents
WO2003082865A1 (en) * 2002-04-01 2003-10-09 Sankyo Company, Limited Medicinal antitumor composition
WO2004013109A1 (ja) * 2002-08-02 2004-02-12 Sankyo Company, Limited レゾルシノール誘導体
US7781464B2 (en) * 2003-01-17 2010-08-24 Bexel Pharmaceuticals, Inc. Heterocyclic diphenyl ethers
US7521465B2 (en) * 2003-01-17 2009-04-21 Bexel Pharmaceuticals, Inc. Diphenyl ether derivatives
US6794401B2 (en) * 2003-01-17 2004-09-21 Bexel Pharmaceuticals, Inc. Amino acid phenoxy ethers
US7718377B2 (en) 2003-05-29 2010-05-18 Kyoto Pharmaceutical Industries, Ltd. Insulin resistance curative and method of screening the same
US7087576B2 (en) * 2003-10-07 2006-08-08 Bexel Pharmaceuticals, Inc. Dipeptide phenyl ethers
CA2543452C (en) * 2003-10-24 2012-03-13 Santen Pharmaceutical Co., Ltd. Therapeutic agent for keratoconjunctival disorder
EP1566202A1 (de) * 2004-02-23 2005-08-24 Sahltech I Göteborg AB Verwendung von resistin-antagonisten zur behandlung von Rheumatoider arthritis
CN1972715A (zh) * 2004-03-29 2007-05-30 三共株式会社 含有胰岛素抵抗改善剂的糖尿病治疗剂
TW200608967A (en) 2004-07-29 2006-03-16 Sankyo Co Pharmaceutical compositions containing with diabetic agent
CA2590883A1 (en) * 2004-12-13 2006-06-22 Daiichi Sankyo Company, Limited Medicinal composition for treating diabetes
CN101115483A (zh) * 2004-12-15 2008-01-30 第一三共株式会社 含有FBPase抑制剂的药物组合物
TW200637856A (en) 2005-01-24 2006-11-01 Sankyo Co Process for producing thiazolidinedion compound and intermediate thereof
TW200722088A (en) * 2005-05-27 2007-06-16 Sankyo Co Diabetes remedy
EP1902713A4 (de) * 2005-07-08 2009-05-13 Daiichi Sankyo Co Ltd Eine thiazolidindion-verbindung enthaltende pharmazeutische zusammensetzung
TW200738266A (en) * 2005-09-29 2007-10-16 Sankyo Co Pharmaceutical agent containing insulin resistance improving agent
KR101409705B1 (ko) 2005-11-28 2014-07-14 센주 세이야꾸 가부시키가이샤 Ｐｐａｒ 아고니스트 함유 의약
TW200838512A (en) * 2007-02-08 2008-10-01 Daiichi Sankyo Co Ltd Crystalline forms of a thiazolidinedione compound and manufacturing methods thereof
BRPI0809643A2 (pt) * 2007-04-05 2014-11-11 Daiichi Sankyo Co Ltd Derivados de heteroarila bicíclica fundida
CN101801941B (zh) 2007-05-21 2012-12-12 千寿制药株式会社 含有ppar△激动剂的药物
US8722710B2 (en) 2007-09-26 2014-05-13 Deuterx, Llc Deuterium-enriched pioglitazone
EP2404918B1 (de) 2009-03-05 2016-11-30 Daiichi Sankyo Company, Limited Pyridinderivat als ppary inhibitor
AU2014236510A1 (en) 2013-03-14 2015-09-24 Deuterx, Llc Deuterium-enriched 2,4-thiazolidinediones and methods of treatment
ES2831326T3 (es) 2014-01-15 2021-06-08 Poxel Sa Métodos para tratar trastornos neurológicos, metabólicos y otros mediante el uso de pioglitazona enantiopura enriquecida con deuterio
US11319313B2 (en) 2020-06-30 2022-05-03 Poxel Sa Crystalline forms of deuterium-enriched pioglitazone
US11767317B1 (en) 2020-06-30 2023-09-26 Poxel Sa Methods of synthesizing enantiopure deuterium-enriched pioglitazone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143930A (en) * 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
IL118474A (en) * 1995-06-01 2001-08-08 Sankyo Co Benzimideol derivatives and pharmaceutical preparations containing them
HUP9601808A3 (en) 1995-07-03 2000-06-28 Sankyo Co Treatment of arteriosclerosis and xanthoma
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
PL352681A1 (en) * 1999-07-19 2003-09-08 Sankyo Company, Limited Preventive and therapeutic agents for cancer

Also Published As

Publication number Publication date
HUP0201334A3 (en) 2002-11-28
EP1180519B1 (de) 2005-05-04
BR0010914A (pt) 2002-02-19
ES2240099T3 (es) 2005-10-16
EP1180519A4 (de) 2002-07-10
AU4948700A (en) 2000-12-12
ZA200109576B (en) 2003-02-20
NZ515570A (en) 2003-11-28
DE60019919D1 (de) 2005-06-09
PT1180519E (pt) 2005-06-30
HK1042087B (en) 2005-09-09
DK1180519T3 (da) 2005-06-13
KR20010113972A (ko) 2001-12-28
HUP0201334A2 (en) 2002-10-28
CZ20014182A3 (cs) 2002-04-17
AU763731B2 (en) 2003-07-31
RU2214410C2 (ru) 2003-10-20
EP1180519A1 (de) 2002-02-20
CN1156473C (zh) 2004-07-07
TR200103353T2 (tr) 2002-04-22
PL351650A1 (en) 2003-05-19
US6706746B2 (en) 2004-03-16
CN1364168A (zh) 2002-08-14
NO20015712D0 (no) 2001-11-23
US20020111373A1 (en) 2002-08-15
NO20015712L (no) 2001-12-20
MXPA01012044A (es) 2002-05-06
TWI284533B (en) 2007-08-01
NO321578B1 (no) 2006-06-06
CZ297927B6 (cs) 2007-05-02
PL209389B1 (pl) 2011-08-31
CA2375017C (en) 2009-05-19
HU229340B1 (en) 2013-11-28
KR20070034112A (ko) 2007-03-27
KR100783348B1 (ko) 2007-12-07
HK1042087A1 (en) 2002-08-02
IL146568A0 (en) 2002-07-25
KR100748053B1 (ko) 2007-08-09
WO2000071540A1 (en) 2000-11-30
CA2375017A1 (en) 2000-11-30
DE60019919T2 (de) 2006-02-16

Similar Documents

Publication Publication Date Title
ATE294799T1 (de) Hydrochloride kondensierter heterozyklen
DE60214392D1 (de) 1,4-disubstituierte benzokondensierte cycloalkyl harnstoffverbindungen
ES2188095T3 (es) Carboxamidas heterociclicas.
PT897904E (pt) 2-metoxibenzofenonas fungicidas
EA200200661A1 (ru) 3-аминохиназолин-2,4-дионовые антибактериальные агенты
NO20053246D0 (no) Kondensert 1,3-dihydroimidazol-ringforbindelse.
TR199902400T2 (xx) Fungusit etkinlik g�steren terkiplerin birle�imleri.
BR0000327B1 (pt) cabeÇa de poÇo.
EA200200699A1 (ru) Оксазолидиноны, обладающие сульфоксиминовой функциональностью
ATE403429T1 (de) Spiropyrazol-verbindungen
SE9903759D0 (sv) Pharmaceutically active compounds
DK1385518T3 (da) Benzimidazolon-forbindelser
IT1320120B1 (it) 2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6-morfolin-4-il-4-0-tolil-piridin-3-il) -isobutirrammide.
WO2001013902A3 (de) Wirkstoffkombination enthaltend Clonidin und Pramipexol
ATE240953T1 (de) Carbazolcarboxamide als 5-ht1f agonisten
DK0952154T3 (da) N-acyl- og N-aroylaralkylamider
BR9914736A (pt) Compostos de 3-(fenil substituìdo)-5-tienil-1,2,4-triazol com atividade contra mosca branca
DE59906902D1 (de) Herbizide 3-(benzo(ox/thi)azol-7-yl)-1h-pyrimidin-2,4-dione
ATE250021T1 (de) Hydroxycyclopentanone
IT1311132B1 (it) Corpo farfallato .
EA200200042A1 (ru) Стабильный раствор ксилометазолина и оксиметазолина
BR0012447A (pt) Análogos de pseudomicina de cadeia lateral de n-acila
DE60214719D1 (de) 8-CHLOR-11-(4-ETHYL-PIPERAZINYL)-DIBENZOiB,Föi1,4öOXAZEPIN ALS ATYPISCH ANTIPSYCHOTISCHER WIRKSTOFF MIT GERINGER AFFINITÄT FÜR DEN D2 REZEPTOR
PT1027891E (pt) Antagonista de neuropeptido y
DE60039695D1 (de) Antifucoidan antikörper

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1180519

Country of ref document: EP